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Problem: Life expectancy for people living with HIV significantly increased with 
widespread use of antiretroviral therapy, resulting in population increases in comorbidity 
prevalence. The increased burden of living with both HIV and comorbidities lowers 
health-related quality of life (HRQoL). 
Methods: Using a descriptive, correlational, cross-sectional design, a convenience sample 
of HIV-positive adults was selected from seven supportive housing communities. 
Comorbidities were assessed using a modified Self-Administered Comorbidity 
Questionnaire, and HRQoL using the Patient-Reported Outcome Measurement 
Information System Scale v1.2 – Global Health. 
Results: A sample of 17 (N = 17) adults reported a mean of 4.2 (SD = 2.8) comorbidities. 
Mean scores for global physical health (GPH) and global mental health (GMH) were 40.8 
(SD = 9.5) and 45.8 (SD = 10.4), respectively. Significant inverse correlations for number 
of comorbidities (rp = -.77, p < .001) and health survey scores (rp = -.80, p < .001) were 
observed with GPH scores. Additional significant inverse correlations for number of 
comorbidities (rp = -.49, p = .047) and health survey scores (rp = -.56, p = .031) were 
observed with GMH scores.  
Implications for Practice: A high comorbidity prevalence accompanied by reports of 
functional limitation and association of decreased HRQoL with increasing number and 
severity of comorbidity guide targeted intervention development, and support the use of 
programs such as chronic disease self-management education and support to improve 
HRQoL in this population of adults living with HIV in supportive housing.
COMORBIDITY AND QUALITY OF LIFE IN HIV 
 
3 
Comorbidity and Quality of Life of HIV-Positive Adults Living in Supportive Housing 
 Due to widespread use of combination antiretroviral therapy (ART) in the 
treatment of HIV, life expectancy for adults diagnosed with HIV has significantly 
increased (Marcus et al., 2016), and these individuals no longer face the threat of a fatal 
illness. Instead, the challenge is meeting the demands of living with a chronic disease. 
Despite improved management, HIV incidence and prevalence in the United States 
indicates a significant issue remains. In 2018, new diagnoses contributed 37,428 cases to 
the number of people over the age of 13 years living with a known diagnosis of HIV, 
bringing the total over one million people (Centers for Disease Control and Prevention, 
2020). However, the problem lies not only in the incidence and prevalence, but also in the 
unintended consequences of treatment advancements, and the effects of said 
consequences; namely, the increasing prevalence of comorbid health conditions (Cole, 
Galárraga, Rahman, & Wilson, 2019) and the impact of comorbidity on health-related 
quality of life (HRQoL).  
  Given the higher high level of care and complex treatment regimens required to 
manage both HIV and chronic comorbid conditions, health outcome evaluation must span 
beyond clinical outcomes to include HRQoL. This patient-reported measure allows the 
patient to create his/her own definition of health, and is widely used in outcome 
evaluation of chronic conditions. HIV-status, alone and with the addition of 
comorbidities, has been associated with low physical and mental HRQoL (Langebeek et 
al., 2017). Thus, examination of the relationship between comorbidity and HRQoL may 
help address disparities observed between HIV-positive and HIV-negative populations. 
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 The purpose of this quality improvement (QI) initiative was to identify areas for 
HRQoL improvement of adults living with HIV in supportive housing. Data for 
demographics, comorbidities, and HRQoL were collected and analyzed to identify 
significant relationships. The primary outcome, HRQoL, was assessed as calculated 
composite scores for global physical health (GPH) and global mental health (GMH). 
Secondary outcome measures, number and severity of comorbidities, were assessed 
through patient report of diagnosis, treatment, and limitations related to comorbid 
conditions. The questions for study were, In adults 18 years of age and older, who are 
living with HIV in supportive housing in an urban Midwest community 
1. What is the comorbidity prevalence and which conditions are most prevalent? 
2. How do sociodemographic factors relate to comorbidity and HRQoL scores? 
3. What relationship exists between participants’ comorbidity and HRQoL scores? 
Review of the Literature 
  A comprehensive search of the literature, limited to full-text, English language, 
peer-reviewed articles published from 2012 to 2019, was conducted via Academic Search 
Complete, CINAHL, MEDLINE, PsycINFO via EBSCOhost, and PubMed. Searches 
using the key terms, “HIV,” “HIV-positive,” “HIV infection,” “HIV comorbid*,” 
“comorbid*,” ‘‘multimorbidity,” ‘‘multiple comorbid*,” “health-related quality of life,” 
and “quality of life,” yielded 5,070 titles. Abstracts of 82 articles were reviewed, and 35 
did not meet preliminary criteria: (a) sample includes people living with HIV, (b) 
examines comorbidity, or (c) use of HRQoL. The full text of the remaining 47 articles 
were reviewed with the criteria: (a) adult subjects, (b) multigender samples, (c) 
quantitative design, and (d) high-income country setting. Following elimination of 35 
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articles for qualitative study design, single-gender samples, and low-income country 
setting, 12 articles remained.  
 Multiple disparities experienced by people living with HIV, including life 
expectancy, comorbidity, and HRQoL, were identified. For instance, comparative 
analysis of life expectancy in large prospective cohort of HIV-positive and HIV-negative 
adults concluded, while consistent access to care and use of ART in HIV-positive adults 
created sharp increases in life expectancy, these factors did not equalize life expectancy 
between the two populations (Marcus et al., 2016). In the years 2008 to 2011, Marcus et 
al. (2016), found a 13-year gap in life expectancy existed between HIV-positive and 
HIV-negative adults. Influences such as early ART initiation (with CD4 count ≥ 500) and 
absence of risk factors (e.g., smoking, substance use, and hepatitis B or hepatitis C 
coinfection) did not eliminate the gap, but reduced it to 5.7 years (Marcus et al., 2016). 
While all life expectancy disparities are not accounted for, these findings highlight the 
importance of access to care, use of ART, and risk reduction in creating positive health 
outcomes for people living with HIV. 
 With the incline in life expectancy also came increasing comorbidity prevalence. 
In a retrospective analysis of Medicaid claims of HIV-positive beneficiaries from 2003 to 
2012, Cole et al. (2019) identified significant increases in comorbidity measures, 
including an increase in the average number of comorbidities from 2.62 to 3.31, and the 
precent of beneficiaries with five or more comorbidities from 21.1% to 27.4%. Similarly, 
a prospective cohort study conducted by Wong et al. (2018) identified significant 
increases in comorbidity; however, lower percentages were identified at baseline and 
conclusion of the study. The number diagnosed with two or more comorbidities started at 
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8.4% in 2000 and increased to 22.4% in 2009 (Wong et al., 2018). Variations in the 
number of conditions evaluated for may contribute to these inconsistencies. 
The most prevalent conditions identified by Cole et al. (2019) were HTN, mental 
illness, pulmonary disorders, liver disease, and cardiovascular disease, and the greatest 
increases were observed in hyperlipidemia, CKD, HTN, and DM (Cole et al., 2019). 
Correspondingly, comparative analysis of HIV-positive and HIV-negative adults 
identified HTN, hyperlipidemia, DM, and CKD as most prevalent, each having 
significantly higher rates in HIV-positive adults. It is important to note, Mayer et al. 
(2018) assessed for ten conditions, heavily focused on malignancies, and did not include 
mental illness, pulmonary disorders, or liver disease. In contrast, Cole et al. (2019) 
assessed for 27 conditions, providing a much more detailed picture of comorbidity, and a 
possible explanation for the variations of the most prevalent conditions. 
In addition to disparities in comorbidity, two cross-sectional studies observed 
disparities in HRQoL of adults living with HIV (Engelhard et al., 2018; Langebeek et al., 
2017). Chiefly, Langebeek et al. (2017) identified an independent association between 
HIV diagnosis and low physical and mental HRQoL using multivariate linear regression. 
Accordingly, small yet significant disparities in physical and mental HRQoL were 
observed compared to HIV-negative adults (Langebeek et al., 2017). The authors 
hypothesized HRQoL differences would intensify with increasing age and number of 
comorbidities. While these hypotheses were rejected, an independent association was 
found between increasing number of comorbidities and low HRQoL in HIV-positive 
adults (Langebeek et al., 2017).  
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Similarly, comparison of a prospective cohort study of adults with DM type 1 and 
randomized control trials (RCTs) of adults with rheumatoid arthritis and DM type 2, 
Engelhard et al. (2018) found significant differences in HRQoL of adults living with HIV 
compared to adults living with other chronic conditions. Specifically, lower mental 
HRQoL was found in adults living with HIV compared to those with the three other 
conditions (Engelhard et al., 2018). In contrast, physical HRQoL of adults living with 
HIV was comparable to those with DM type 1 and DM type 2, and significantly higher 
than those with rheumatoid arthritis. Additional evidence of the association between 
comorbidity and HRQoL was demonstrated by significantly greater odds of low physical 
HRQoL scores with severe comorbidity (i.e., past cardiovascular event, non-AIDS-
related cancer, end-stage kidney disease, and insulin therapy in DM) compared to having 
no comorbidities (Engelhard et al., 2018). 
Behavioral and social modifiable factors have also been found to impact quality-
of-life domains (Langebeek et al., 2017; Webel, Sattar, Schreiner, & Phillips, 2016). 
Langebeek et al. (2017) found significantly greater prevalence of tobacco use in HIV-
positive adults, and identified substance use, including excessive alcohol intake and 
tobacco use, to negatively impact mental HRQoL. Furthermore, a cross-sectional study 
conducted by Webel et al. (2016) demonstrated moderate, but significant relationships 
between social resource variables and quality of life domains; life satisfaction quality of 
life increased with increasing social belonging and social capital, and overall functioning 
quality of life increased with increasing social belonging.  
Reliable and valid instruments are required to assess comorbidity and HRQoL, 
and allow for sample and population comparisons. The Self-Administered Comorbidity 
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Questionnaire (SCQ; Sangha, Stucki, Liang, Fossel, and Katz, 2003) is a patient self-
report tool used to assess comorbidity by determining the presence, treatment, and 
functional limitation caused by common comorbid conditions. Cross-sectional 
comparison of the SCQ to the Charlson Comorbidity Index, a widely used comorbidity 
assessment using medical record review, support the tool’s validity and reliability. The 
overall agreeability between the items of each tool was 90%, and test-retest reliability 
statistics were significant (r = .94; Sangha et al., 2003).  
 To assess effects of non-HIV-related comorbidities in adults living with HIV, a 
disease-generic instrument such as the Patient-Reported Outcome Measurement 
Information System (PROMIS) Scale v1.2 – Global Health is best suited. A cross-
sectional comparative study conducted by Hays, Bjorner, Revicki, Spritzer, and Cella 
(2009) demonstrated good internal consistency reliability for GPH and GMH, α = .81 and 
α = .86, respectively. Comparison of results of the PROMIS Scale v1.2 – Global Health 
with results of the EuroQol- 5 Dimension, a widely used tool to assess generic HRQoL, 
demonstrated high intercorrelation (r = .63) and shared variance (R2 = 0.60; Hays et al., 
2009), and support the tool’s validity and reliability.  
Social and behavioral interventions have shown success in improvement of 
HRQoL. A systematic review and meta-analysis conducted by Bhatta, Liabsuetrakul, and 
McNeil (2017) examined 28 RCTs, in which 21 found improvement in quality-of-life 
domains through social and behavioral interventions. The authors reported, exercise 
programs achieved improvement in a significant number of quality-of-life domains, most 
notably general health, mental health, environment, and physical function domains. 
Although the evidence could not strongly support social and behavioral interventions in 
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HRQoL improvement (Bhatta et al., 2017), social and behavioral interventions designed 
to prevent and manage comorbidities and improve social resources may be useful. 
 Physical and mental HRQoL of people living with HIV is impacted by many 
factors spanning across sociodemographic characteristics, clinical health, and social 
wellbeing. Although generalizability was limited by settings in private (Marcus et al., 
2016) and universal health care systems (Engelhard et al., 2018; Langebeek et al., 2017), 
the quantity of evidence suggests modifiable factors are essential in HRQoL outcomes. 
Recent quantitative research suggests interventions targeted at improved comorbidity 
management and prevention (Engelhard et al., 2018; Langebeek et al., 2017), modifiable 
behavior factors (Langebeek et al., 2017), and increasing social resources (Webel et al., 
2016) may be useful in improving HRQoL. 
 The Iowa Model of Evidence-Based Practice-Revised provided the theoretical 
framework for this QI initiative. This model is an algorithm-based, systematic approach 
to evidence-based practice and focuses on the appraisal and synthesis of literature to 
inform the development of pilot programs (Buckwalter et al., 2017). Using this model, 
stakeholder meetings and review of the literature guided development of a plan to assess 
comorbidity prevalence and HRQoL in HIV-positive adults living in supportive housing. 
Methods 
Design 
The design for this initiative was descriptive, correlational, and cross-sectional. 
Data were collected via self-administered questionnaires assessing participants’ 
comorbidities and HRQoL. 
 




This initiative took place in seven supportive housing communities for otherwise 
homeless HIV-positive adults and their dependents located in an urban Midwest 
community. These communities, operated by a non-profit organization serving its 
mission to improve the health and well-being of individuals impacted by HIV, contain 
103 apartments, providing long-term stable housing for 186 adults and children.  
Sample 
A convenience sample was obtained using the inclusion criteria (a) current HIV-
positive community resident, (b) 18 years of age or older, and (d) and consent to 
participate. Non-residents and individuals under the age of 18 were excluded. To 
maintain confidentiality of HIV status, all adult residents were welcomed to participate; 
however, HIV-negative residents were not included in data analysis.  
Approval Process 
Approval was first obtained from the doctoral committee at the University of 
Missouri-St. Louis (UMSL). A letter approving the QI initiative’s planned procedures 
was then obtained from the collaborating organization. The UMSL Institutional Review 
Board granted final project approval.  
Procedures 
Initial planning began with problem identification and early initiative formation 
between the initiative leader, doctoral committee, and staff from the collaborating 
organization. As an introduction to the community, the initiative leader attended tenant 
meetings before implementation. Due to the onset of the COVID-19 pandemic, the 
implementation plan was modified. The plan shifted from group implementation during 
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chronic disease self-management-focused educational sessions to on-site visits with 
individual interaction. One week before scheduled visits, the Client Services Coordinator 
for each community hung flyers in shared areas, and all households received a packet 
containing a copy of the consent to participate and a detailed initiative brochure with the 
date and time of the scheduled visit. Accompanied by the Client Services Coordinator, 
the initiative leader attempted contact at every household. The purpose, requirements, 
risks, and benefits of involvement were reviewed upon contact, and if the resident agreed 
to participate, understanding was verified, and informed consent was obtained. In place 
of the educational sessions, a self-management educational booklet was developed 
offered to all contacts regardless of participation.  
Data Collection and Analysis 
Data collection occurred between June 26, 2020, and July 7, 2020. Predictor 
variables collected were age, gender, race, education level, income, household size, 
insurance status, tobacco use, and HIV-status. Scores for GPH and GMH, were obtained 
using the PROMIS Scale v1.2 – Global Health. This scale asks ten questions related to 
physical and mental health with a five-category response scale, ranging from 1 (poor) to 
5 (excellent). Responses were scores by the HealthMeasures Scoring Service and returned 
t scores for GPH and GMH (μ = 50, σ = 10). The health survey, a modified version of the 
SCQ, assessed number of comorbidities and their severity, or the health survey score (HS 
score). The HS score was calculated by assigning one point for each ‘yes’ response for 
diagnosis, treatment, and functional limitation caused by 14 common conditions, with a 
highest possible score of 42; higher scores indicated greater comorbidity severity.  
COMORBIDITY AND QUALITY OF LIFE IN HIV 
 
12 
Data were de-identified, prepared for statistical analysis using Microsoft Excel, 
and analyzed using Intellectus Statistics software. Descriptive statistics summarized all 
data and were reported as frequencies for sample demographics (Figure 1) and 
comorbidity prevalence (see Figure 2) and mean and standard deviation for number of 
comorbidities, HS score, GPH scores, and GMH scores (see Figure 3). Sample means for 
GPH and GMH scores were examined using two-tailed, one-pair t tests. Statistical 
differences in number of comorbidities, HS score, GPH scores, and GMH scores between 
demographic groups were determined using one-way ANOVA. Relationships between 
comorbidity scores and HRQoL scores were analyzed using Pearson correlation and 
point-biserial correlation. Significance for all inferential statistics was set at .05.  
Results 
 From the 186 residents, 17 (N = 17) HIV-positive adult residents completed the 
questionnaires and met inclusion criteria. HS scores for two participants were excluded 
from analysis due to incomplete data. Participants were ages 35-50 years (n = 7, 41.2%) 
and 51+ years (n = 7, 41.2%), male (n = 10, 58.8%), and Black (n = 16, 94.1%). See 
Figure 1 for full demographic profile.  
A total of 72 comorbidities were reported by the sample, with the most prevalent 
conditions being lung disease (n = 10, 58.8%), HTN (n = 9, 52.9%), depression (n = 9, 
52.9%), arthritis (n = 9, 52.9%), and back pain (n = 9, 52.9%; see Figure 2). Sample 
means for number of comorbidities, health survey score, GPH score, and GMH score 
were 4.2 (SD =2.8), 11.2 (SD = 8.1), 40.8 (SD = 9.5), and 45.8 (SD = 10.4), respectively. 
The two-tailed, one-sample t test found the sample mean GPH score to be significantly 
different from the reference population (p = .001; see Figure 3). Results of the one-way 
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ANOVA demonstrated significant variance in number of comorbidities and GPH by age 
group, F(2, 14) = 3.80, p = .045, ηp2 = 0.36 and F(2, 14) = 4.85, p = .025, ηp2 = 0.41, 
respectively. Post-hoc analysis showed differences in number of comorbidities and GPH 
scores between ages 18-34 years and 35-50 years were significant (p = .049 and p = .036, 
respectively; see Figure 3).  
Results of Pearson correlation demonstrated strong inverse correlations for 
number of comorbidities (rp = -.77, p < .001) and health survey scores (rp = -.80, p < 
.001) with GPH scores. As well as, weak to moderate-strength inverse correlations for 
number of comorbidities (rp = -.49, p = .047) and health survey scores (rp = -.56, p = 
.031) with GMH scores. Moderate to strong inverse correlations for back pain (rpb = -.64, 
p = .011), lung disease (rpb = -0.72, p = .002), and GI disorders (rpb = -.55, p = .024) with 
GPH scores were observed. For GMH scores, depression was found to have a strong 
inverse correlation (rpb = -.71, p = .003) and GI disorders a moderate-strength inverse 
correlation (rpb = -.59, p = .024). No additional significant correlations were identified. 
Discussion 
The prevalence of comorbidity is high in this sample of HIV-positive adults living 
in supportive housing. All but one participant reported at least one comorbidity. 
Surprisingly, more than half of reported conditions (57%, n = 41) cause participants to 
feel functionally limited. More surprisingly, in 89% of cases with functional limitation (n 
= 36), limitation is perceived even in the presence of health care provider management. In 
light of sustained limitation, future inquiry into the types of limitations experienced and 
possible explanations for the persistence including treatment regimen understanding, 
treatment adherence, and barriers to adherence, are recommended. Chronic disease self-
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management education and support may be beneficial in addressing sustained limitation, 
supported by the greater strength of relationships identified between HS scores and scores 
for GPH and GMH, compared to number of comorbidities. 
Compared to the general population, this sample has a significantly lower lever of 
GPH, which is also associated with an increasing number and severity of comorbidities in 
participants. These findings implicate GPH as an area of concern that warrants 
intervention and continued surveillance. They also suggest programming focused on 
prevention and improved management of comorbidity may address the disparity. 
Additional disparities within the sample for number of comorbidities and GPH scores 
were identified between age groups, with a significantly higher number of comorbidities 
and significantly lower GPH scores found in participants age 35-50 years compared to 
participants ages 18-34 years. Therefore, residents ages 35-50 years may experience the 
greatest benefit from interventions addressing comorbidity and GPH. Considering the 
timing of assessment during the global COVID-19 pandemic, reassessment in the post-
pandemic period is recommended to identify any impacts reduced access to care and 
isolation may have on comorbidity and HRQoL. 
 At the condition-specific level, the moderate to strong inverse relationships 
between comorbidity factors and HRQoL scores suggests the most significant 
improvements may be achieved in GPH with lung disease-targeted interventions and 
GMH with depression-targeted interventions, whereas modest improvements in GPH 
may be achieved through interventions targeting back pain. Both GPH and GMH scores 
were correlated with GI disorders; however, the sample’s prevalence of GI disorders 
sample was low (n = 3, 17.6%) and targeted interventions may not be highly beneficial. 
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This QI initiative provides the collaborating organization with important baseline 
data that can facilitate achievement of their mission to improve the health and quality of 
life of people impacted by HIV, even so, limitations exist. First, the cross-sectional 
design provides only a snapshot in time and cannot identify data trends and causal 
relationships. Next, the small and homogenous sample resulted in insufficient sample 
sizes among variable categories, causing exclusion of multiple sociodemographic 
variables from statistical analysis. Finally, comorbidity assessment using self-
administered questionnaires can potentially result in misreporting of comorbid 
conditions. To add, consideration of health literacy capabilities of the study population 
should be made when using self-administered tools.  
Conclusion 
 Multiple areas were identified for HRQoL improvement of adults living with HIV 
in supportive housing in a Midwest community. This sample demonstrated a high 
prevalence of comorbidity accompanied by considerable reports of functional limitation 
related to comorbid diagnoses. Low scores for GPH were reported, with the lowest scores 
observed in participants ages 35-50 years. Three of the most prevalent conditions, 
depression, back pain, and lung disease, were also found to have significant relationships 
with GPH and GMH scores. These findings guide targeted intervention development, and 
support the use of programs such as chronic disease self-management education and 
support to improve HRQoL in this population of adults living with HIV in supportive 
housing. 
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Figure 1. Frequencies and percentages for sample demographics. N = 17. Due to 
rounding, totals may not equal 100%. Data labels for race, gender, and income include: 
‘other’ race (n = 1, 5.9%), ‘other’ gender (n = 1, 5.9%), and ‘$12,000-$30,999’ income (n 
= 1, 5.9%). * represents category ‘HS diploma/GED’ category. 
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Figure 2. Frequency of diagnosis, treatment, and functional limitation by comorbid 
condition. N = 17. Diagnosis of liver disease was not reported by any participants and 
was excluded from the figure. * indicates category was missing one response, and 
** indicates category was missing two responses. 




Figure 3. Comparison of means for global physical health (GPH), global mental health 
(GMH), number of comorbidities, and health survey score stratified by age. N = 17 for 
GPH, GMH, and number of comorbidities. N =15 for health survey score. 
* Two-tailed one sample t-test demonstrated significant difference in sample mean for 
GPH score compared to reference population (p = .001). 
+ Number of comorbidities for participants ages 35-50 years were significantly higher 
than participants ages 18-34 years (p = .049). 
++ GPH scores for participants ages 35-50 years were significantly lower than 
participants ages 18-34 years (p = .036). 
 
